Resorbable, Phsophorylated Poly(ester urea) Surgical Adhesive to Enhance Fracture Healing
可吸收的磷酸化聚(酯脲)手术粘合剂可促进骨折愈合
基本信息
- 批准号:10674973
- 负责人:
- 金额:$ 16.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationActinsAdhesionsAdhesivesAmino AcidsAwardBiocompatible MaterialsBiologic CharacteristicBiomechanicsBiomedical EngineeringBone MarrowBone Marrow Stem CellBone callusBreathingCalciumCartilageCellsChemicalsChest wall structureChondrocytesClinicalCollagenContractsCritical CareCuesCytoskeletal ModelingDataDedicationsDepositionDevelopmentElasticityElastomersEngineeringEstersEthanolExhibitsExternal Fixation DevicesFailureFlail ChestFocal AdhesionsFormulationFoundationsFractureFutureGenerationsGlycolsGoalsImmobilizationIn VitroIncidenceInjectableInjectionsInjuryInvestigationLaboratory ResearchLifeMechanicsMentorsMetabolicModelingModificationModulusMusculoskeletalOperative Surgical ProceduresOrthopedicsOsteoblastsPainPatientsPerformancePhosphorylationPhosphoserinePlayPneumoniaPolymersPositioning AttributeProgram DevelopmentPropertyPublic HealthRattusResearchResearch PersonnelRib FracturesScientistStem Cell ResearchStromal CellsSurfaceSurgeonTensile StrengthTestingTissue EngineeringTraumaTrauma patientTraumatic injuryUnited StatesUnited States National Institutes of HealthUniversitiesUreaVertebral columnWorkacute carebasebiodegradable polymerbonebone fracture repairbone healingcareercareer developmentclinical practicecopolymercortical bonedensityelastomericexperienceexperimental studyhealinghigh riskimprovedin vivoinnovationinorganic phosphateinsightinterfaciallong bonematerials sciencemechanical propertiesmechanical signalminimally invasivemonomernovelnovel therapeuticspolymerizationprofessorpulmonary functionreparative processrib bone structuresafety testingskillsstoichiometrysurgery materialtrauma caretreatment strategywound healing
项目摘要
PROJECT SUMMARY
This proposal presents a five-year research career development program focused on optimizing the physical
and biological characteristics of phosphorylated poly(ester ureas) (pPEU) for the stabilization and healing of rib
fractures. The candidate is currently an Assistant Professor of Surgery and acute and critical care trauma
surgeon at Duke University, with previous research experience in biologic materials and tissue engineering
research. He has now chosen to focus on materials science and mechanical engineering with a diverse
mentoring committee of investigators with expertise in materials, polymers, musculoskeletal reparative
processes and stem cell research. The proposed experiments and didactic work will provide the candidate with
a unique set of skills that will help him transition to independence as a surgeon-scientist and enable him to fill a
significant “experience gap” in the field of research dedicated to rib fractures and wound healing.
Rib fractures account for nearly 40% of all bone fractures sustained in the each year, with over a quarter million
rib injuries. These injuries can have long-lasting effects, sometimes even for life. Over half of rib fracture patients
contract pneumonia, and nearly two thirds will still experience significant pain in the chest wall years after
sustaining the injury. While stabilization of a fracture promotes faster healing and decreased rates of non-union
(failure of a broken bone to heal), rib fractures present a unique challenge in that immobilization can only be
accomplished through invasive surgical intervention. Therefore, unlike long bone fractures where immediate
stabilization is standard, this is reserved in rib fractures for only the most severe cases. Poly(ester ureas) (PEU)
are amino acid based biodegradable polymers with bone like mechanical properties. One such phosphorylated
PEU (pPEU) copolymer, based on phosphoserine (pSer) is ethanol soluble allowing for injection, with strong
bone adhesion and high elastic moduli, making pPEU’s ideal as an innovative, non-invasive solution for the
stabilization of rib fractures. However, the effect of pSer stoichiometry on PEU copolymer osteoinduction remains
unknown, as well as if a provisional elastomeric callus using resorbable PEU based adhesive can accelerate
bone healing through early fracture stabilization. This proposal will determine the relationships between the
physical and biologic characteristics of injectable pSer-PEU for osteoinduction and test the safety and
performance of pSer-PEU in a rat model of rib fracture. The work of this proposal will 1) characterize the
relationship of pSer stoichiometry within the PEU copolymers on biomechanics (tensile strength, elastic modulus,
and stiffness), and interfascial adhesion of pSer-PEU; 2) quantify bone marrow stromal cell (BMSC) cytoskeletal
reorganization and osteoinduction to increased stiffness, and 3) evaluate fracture stability and callus formation
in a rat rib fracture model with best performing pSer-PEU. The results of this work will serve as the basis for
future projects focused on using functionalized biomaterials to understand the cellular mechanisms of fracture
healing in order to optimize healing in the high risk trauma patient.
项目概要
该提案提出了一个为期五年的研究职业发展计划,重点是优化身体素质
磷酸化聚酯脲(pPEU)用于肋骨稳定和愈合的生物学特性
该候选人目前是外科和急性和重症护理创伤的助理教授。
杜克大学外科医生,拥有生物材料和组织工程研究经验
他现在选择专注于材料科学和机械工程的多元化研究。
由具有材料、聚合物、肌肉骨骼修复专业知识的研究人员组成的指导委员会
拟议的实验和教学工作将为候选人提供过程和干细胞研究。
一套独特的技能将帮助他过渡到作为一名外科医生科学家的独立地位,并使他能够填补
在肋骨骨折和伤口愈合的研究领域存在显着的“经验差距”。
肋骨骨折占每年所有骨折的近 40%,超过 25 万例
肋骨损伤。这些损伤可能会产生长期影响,有时甚至对一半以上的肋骨骨折患者造成终生影响。
感染肺炎,数年后近三分之二的胸壁仍会感到剧烈疼痛
维持骨折的稳定性可促进更快的愈合并降低不愈合率。
(断骨无法愈合),肋骨骨折带来了独特的挑战,因为只能通过固定来固定
因此,与长骨骨折不同,它是通过侵入性手术干预来完成的。
稳定是标准配置,仅在最严重的情况下保留肋骨骨折。
是一种基于氨基酸的生物可降解聚合物,具有类似骨的机械性能。
基于磷酸丝氨酸 (pSer) 的 PEU (pPEU) 共聚物可溶于乙醇,可注射,具有强效
骨粘附力和高弹性模量,使 pPEU 成为理想的创新、非侵入性解决方案
然而,pSer 化学计量对 PEU 共聚物骨诱导的影响仍然存在。
未知,以及使用可吸收 PEU 粘合剂的临时弹性愈伤组织是否可以加速
通过早期骨折稳定来实现骨愈合。该提案将确定骨折之间的关系。
用于骨诱导的可注射 pSer-PEU 的物理和生物学特性并测试其安全性和
pSer-PEU 在肋骨骨折大鼠模型中的性能 本提案的工作将 1) 表征
PEU 共聚物内 pSer 化学计量与生物力学(拉伸强度、弹性模量、
和硬度),以及 pSer-PEU 的筋膜间粘附力 2)量化骨髓基质细胞 (BMSC) 细胞骨架;
重组和骨诱导以增加刚度,3) 评估骨折稳定性和愈伤组织形成
在具有最佳性能的 pSer-PEU 的大鼠肋骨骨折模型中,这项工作的结果将作为
未来的项目侧重于使用功能化生物材料来了解骨折的细胞机制
愈合以优化高风险创伤患者的愈合。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joseph S. Fernandez-Moure其他文献
Joseph S. Fernandez-Moure的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joseph S. Fernandez-Moure', 18)}}的其他基金
Resorbable, Phsophorylated Poly(ester urea) Surgical Adhesive to Enhance Fracture Healing
可吸收的磷酸化聚(酯脲)手术粘合剂可促进骨折愈合
- 批准号:
10283703 - 财政年份:2021
- 资助金额:
$ 16.69万 - 项目类别:
Resorbable, Phsophorylated Poly(ester urea) Surgical Adhesive to Enhance Fracture Healing
可吸收的磷酸化聚(酯脲)手术粘合剂可促进骨折愈合
- 批准号:
10474458 - 财政年份:2021
- 资助金额:
$ 16.69万 - 项目类别:
相似国自然基金
肌动蛋白成核促进因子SHRC的结构和分子机制的研究
- 批准号:32301034
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
染色质重塑因子肌动蛋白样6A在视网膜变性中的作用机制及干预研究
- 批准号:82371081
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
肌动蛋白结合蛋白Xirp2介导基质刚度诱导心肌细胞肥大的力学生物学机制
- 批准号:12372314
- 批准年份:2023
- 资助金额:52 万元
- 项目类别:面上项目
肌动蛋白结合蛋白ANLN在胆汁淤积性肝损伤后肝再生过程中的作用及机制研究
- 批准号:82370648
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
WDR1介导的肌动蛋白解聚动态平衡在小脑浦肯野细胞衰老性焦亡中的作用研究
- 批准号:32371053
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Microbial Control of Host Intercellular Communication
宿主细胞间通讯的微生物控制
- 批准号:
10661500 - 财政年份:2022
- 资助金额:
$ 16.69万 - 项目类别:
Uncovering the dual anabolic and anti-catabolic effects of Pyk2 inhibition on bone mass
揭示 Pyk2 抑制对骨量的双重合成代谢和抗分解代谢作用
- 批准号:
10688085 - 财政年份:2022
- 资助金额:
$ 16.69万 - 项目类别:
Prune Belly Syndrome: Mechanisms of Filamin A Mutations
李子腹综合症:Filamin A 突变机制
- 批准号:
10675735 - 财政年份:2022
- 资助金额:
$ 16.69万 - 项目类别:
Alterations of leukocyte integrin signaling leading to diabetes and autoimmunity
白细胞整合素信号的改变导致糖尿病和自身免疫
- 批准号:
10683384 - 财政年份:2022
- 资助金额:
$ 16.69万 - 项目类别:
Cancer cell fusion; A mechanism driving breast tumor heterogeneity and metastasis
癌细胞融合;
- 批准号:
10640109 - 财政年份:2020
- 资助金额:
$ 16.69万 - 项目类别: